1. Home
  2. SLRX vs FICO Comparison

SLRX vs FICO Comparison

Compare SLRX & FICO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SLRX
  • FICO
  • Stock Information
  • Founded
  • SLRX N/A
  • FICO 1956
  • Country
  • SLRX United States
  • FICO United States
  • Employees
  • SLRX N/A
  • FICO N/A
  • Industry
  • SLRX Biotechnology: Pharmaceutical Preparations
  • FICO Business Services
  • Sector
  • SLRX Health Care
  • FICO Consumer Discretionary
  • Exchange
  • SLRX Nasdaq
  • FICO Nasdaq
  • Market Cap
  • SLRX 2.9M
  • FICO 32.2B
  • IPO Year
  • SLRX N/A
  • FICO 1987
  • Fundamental
  • Price
  • SLRX $5.43
  • FICO $1,550.12
  • Analyst Decision
  • SLRX
  • FICO Buy
  • Analyst Count
  • SLRX 0
  • FICO 12
  • Target Price
  • SLRX N/A
  • FICO $2,064.50
  • AVG Volume (30 Days)
  • SLRX 129.8K
  • FICO 323.5K
  • Earning Date
  • SLRX 11-13-2025
  • FICO 11-05-2025
  • Dividend Yield
  • SLRX N/A
  • FICO N/A
  • EPS Growth
  • SLRX N/A
  • FICO 34.32
  • EPS
  • SLRX N/A
  • FICO 25.55
  • Revenue
  • SLRX N/A
  • FICO $1,928,927,000.00
  • Revenue This Year
  • SLRX N/A
  • FICO $18.02
  • Revenue Next Year
  • SLRX N/A
  • FICO $13.86
  • P/E Ratio
  • SLRX N/A
  • FICO $60.42
  • Revenue Growth
  • SLRX N/A
  • FICO 16.66
  • 52 Week Low
  • SLRX $4.50
  • FICO $1,300.00
  • 52 Week High
  • SLRX $108.00
  • FICO $2,402.52
  • Technical
  • Relative Strength Index (RSI)
  • SLRX 42.11
  • FICO 59.24
  • Support Level
  • SLRX $4.50
  • FICO $1,511.04
  • Resistance Level
  • SLRX $5.65
  • FICO $1,598.00
  • Average True Range (ATR)
  • SLRX 0.42
  • FICO 41.25
  • MACD
  • SLRX 0.22
  • FICO 13.98
  • Stochastic Oscillator
  • SLRX 54.50
  • FICO 77.93

About SLRX Salarius Pharmaceuticals Inc.

Salarius Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing effective treatments for cancers with high, unmet medical needs. The company has focused on two classes of drugs that address gene dysregulation: targeted protein inhibitors and targeted protein degradation. Its Pipeline includes seclidemstat (SP-2577), a small molecular inhibitor, and SP-3164, a small molecular protein degrader.

About FICO Fair Isaac Corproation

Founded in 1956, Fair Isaac Corporation is a leading applied analytics company. Fair Isaac is primarily known for its FICO credit scores, which is a widely used industry benchmark to determine the creditworthiness of an individual consumer. The firm's US-centric credit scores business accounts for most of the firm's profits and consists of business-to-business and business-to-consumer services. In addition to scores, Fair Isaac also sells software primarily to financial institutions for areas such as analytics, decision-making, customer workflows, and fraud.

Share on Social Networks: